 |
|
U-M researchers use nanoparticles to target brain cancer
November 15, 2006Nanoparticles can carry drugs designed to image, treat tumors, study finds
ANN ARBOR, Mich. - Tiny particles one-billionth of a meter in size can be loaded with high concentrations of drugs designed to kill brain cancer. What's more, these nanoparticles can be used to image and track tumors as well as destroy them, according to researchers at the University of Michigan Comprehensive Cancer Center.
Researchers incorporated a drug called Photofrin along with iron oxide into nanoparticles that would target cancerous brain tumors. Photofrin is a type of photodynamic therapy, in which the drug is drawn through the blood stream to tumor cells; a special type of laser light activates the drug to attack the tumor. Iron oxide is a contrast agent used to enhance magnetic resonance imaging, or MRI.
"Photofrin goes into tumor blood vessels and collapses the vasculature, which then starves the tumor of the blood flow needed to survive. The problem with free photofrin therapy is that it can cause damage to healthy tissue. In our study, the nanoparticle becomes a vehicle to deliver the drug directly to the tumor," says study author Brian Ross, Ph.D., professor of radiology at the U-M Medical School and co-director of Molecular Imaging at the U-M Comprehensive Cancer Center.
Photofrin has been used to treat several types of cancer, including esophageal, bladder and skin cancers. It works by traveling through blood vessels until it reaches the vessels supplying blood to the tumor. When activated by light, the Photofrin collapses these blood vessels, starving the tumor of the blood it needs to survive.
Results of the study appear in the Nov. 15 issue of Clinical Cancer Research.
"Thinking outside the box is a must for developing brain cancer treatments. Drugs don't get into the brain when delivered in the normal way, which explains in part why some current treatments for brain tumors are generally not effective. Targeting the tumor vasculature with nanoparticles containing a payload will overcome these issues," says study author Alnawaz Rehemtulla, Ph.D., professor of radiology and radiation oncology at the U-M Medical School and professor of environmental health sciences at the School of Public Health.
Treating brain tumors is traditionally difficult because of the blood-brain barrier, which prevents harmful substances from traveling through the bloodstream into the brain. In order for chemotherapy to treat a tumor, it must penetrate this barrier.
Researchers tested the nanoparticles in cell cultures and animal models. The studies showed the nanoparticles traveled to the tumor, resulting in less Photofrin exposure throughout the body and enhanced exposure within the tumor. This allowed a larger window for activating the drug with light. It also would eliminate a common side effect of photodynamic therapy, in which healthy skin becomes sensitive to light.
In rat studies, researchers found those treated traditionally with Photofrin survived 13 days, while rats treated with Photofrin incorporated into a nanoparticle survived an average of 33 days. Forty percent of the rats remained disease-free six months after treatment.
The researchers also found twice the amount of the contrast agent at the tumor site when using targeted nanoparticles, suggesting the nanoparticles were attracted to the tumor site.
The advantage of this delivery system is the ability to attack the tumor with higher doses of a drug while sparing normal tissue from a drug's toxic side effects.
"Our research suggests that you can take a drug that may be toxic to normal tissue - it could be any type of drug, not just photodynamic - and you could deliver higher doses of that drug for a more powerful punch," says Rehemtulla, co-director of Molecular Imaging at the U-M Comprehensive Cancer Center.
If nanoparticle delivery proves to be safe in humans, it will allow researchers to re-examine previously developed drugs that were discarded because they caused too many dangerous side effects in patients.
By combining the drug with a contrast agent, researchers were able using imaging techniques to determine whether the drug actually got to the tumor. This technique could have potential to diagnosis brain tumors early, as well as to help researchers determine when to deliver a drug or when to administer the next dose.
Further lab research is needed before the nanoparticle technology can be tested in clinical trials. More than 18,800 people will be diagnosed with brain cancer this year, and 12,820 will die from it. For information about treatments that are currently available, call U-M's Cancer AnswerLine at 800-865-1125.
University of Michigan Health System
"Photofrin goes into tumor blood vessels and collapses the vasculature, which then starves the tumor of the blood flow needed to survive. The problem with free photofrin therapy is that it can cause damage to healthy tissue. In our study, the nanoparticle becomes a vehicle to deliver the drug directly to the tumor," says study author Brian Ross, Ph.D., professor of radiology at the U-M Medical School and co-director of Molecular Imaging at the U-M Comprehensive Cancer Center.
Photofrin has been used to treat several types of cancer, including esophageal, bladder and skin cancers. It works by traveling through blood vessels until it reaches the vessels supplying blood to the tumor. When activated by light, the Photofrin collapses these blood vessels, starving the tumor of the blood it needs to survive.
Results of the study appear in the Nov. 15 issue of Clinical Cancer Research.
"Thinking outside the box is a must for developing brain cancer treatments. Drugs don't get into the brain when delivered in the normal way, which explains in part why some current treatments for brain tumors are generally not effective. Targeting the tumor vasculature with nanoparticles containing a payload will overcome these issues," says study author Alnawaz Rehemtulla, Ph.D., professor of radiology and radiation oncology at the U-M Medical School and professor of environmental health sciences at the School of Public Health.
Treating brain tumors is traditionally difficult because of the blood-brain barrier, which prevents harmful substances from traveling through the bloodstream into the brain. In order for chemotherapy to treat a tumor, it must penetrate this barrier.
Researchers tested the nanoparticles in cell cultures and animal models. The studies showed the nanoparticles traveled to the tumor, resulting in less Photofrin exposure throughout the body and enhanced exposure within the tumor. This allowed a larger window for activating the drug with light. It also would eliminate a common side effect of photodynamic therapy, in which healthy skin becomes sensitive to light.
In rat studies, researchers found those treated traditionally with Photofrin survived 13 days, while rats treated with Photofrin incorporated into a nanoparticle survived an average of 33 days. Forty percent of the rats remained disease-free six months after treatment.
The researchers also found twice the amount of the contrast agent at the tumor site when using targeted nanoparticles, suggesting the nanoparticles were attracted to the tumor site.
The advantage of this delivery system is the ability to attack the tumor with higher doses of a drug while sparing normal tissue from a drug's toxic side effects.
"Our research suggests that you can take a drug that may be toxic to normal tissue - it could be any type of drug, not just photodynamic - and you could deliver higher doses of that drug for a more powerful punch," says Rehemtulla, co-director of Molecular Imaging at the U-M Comprehensive Cancer Center.
If nanoparticle delivery proves to be safe in humans, it will allow researchers to re-examine previously developed drugs that were discarded because they caused too many dangerous side effects in patients.
By combining the drug with a contrast agent, researchers were able using imaging techniques to determine whether the drug actually got to the tumor. This technique could have potential to diagnosis brain tumors early, as well as to help researchers determine when to deliver a drug or when to administer the next dose.
Further lab research is needed before the nanoparticle technology can be tested in clinical trials. More than 18,800 people will be diagnosed with brain cancer this year, and 12,820 will die from it. For information about treatments that are currently available, call U-M's Cancer AnswerLine at 800-865-1125.
University of Michigan Health System
Nanoparticle Current Events and Nanoparticle News RSSSmall nanoparticles bring big improvement to medical imaging
If you're watching the complex processes in a living cell, it is easy to miss something important-especially if you are watching changes that take a long time to unfold and require high-spatial-resolution imaging.
Duke develops nano-scale drug delivery for chemotherapy
Going smaller could bring better results, especially when it comes to cancer-fighting drugs.
Hard Rain: Pitt-led Researchers Create Nano-Particle Coating to Prevent Freezing Rain Buildup on Roads, Power Lines
Preventing the havoc wrought when freezing rain collects on roads, power lines, and aircrafts could be only a few nanometers away.
Berkeley Researchers Find New Route to Nano Self-Assembly
If the promise of nanotechnology is to be fulfilled, nanoparticles will have to be able to make something of themselves. An important advance towards this goal has been achieved by researchers with the U.S. Department of Energy's Lawrence Berkeley National Laboratory (Berkeley Lab) who have found a simple and yet powerfully robust way to induce nanoparticles to assemble themselves into complex arrays.
Detecting the undetectable in prostate cancer screening
A team of Northwestern University researchers, using an extremely sensitive tool based on nanotechnology, has detected previously undetectable levels of prostate-specific antigen (PSA) in patients who have undergone radical prostatectomy.
Clemson bioengineer uses nanoparticles to target drugs
Clemson bioengineer Frank Alexis is designing new ways to target drugs and reduce the chances for side effects.
Novel polymer delivers genetic medicine, allows tracking
Theresa M. Reineke, associate professor of chemistry in the College of Science, and colleagues in her lab at Virginia Tech and at the University of Cincinnati have developed a new molecule that can travel into cells, deliver genetic cargo, and packs a beacon so scientists can follow its movements in living systems.
Engineers Produce 'How-To' Guide for Controlling the Structure of Nanoparticles
Tiny objects known as nanoparticles are often heralded as holding great potential for future applications in electronics, medicine and other areas.
New discovery reveals fate of nanoparticles in human cells
Scientists funded by the Biotechnology and Biological Sciences Research Council (BBSRC) have uncovered what happens to biomimetic nanoparticles when they enter human cells.
Topical erectile dysfunction therapy shows promise
An innovative drug-delivery system - nanoparticles encapsulating nitric oxide or prescription drugs - shows promise for topical treatment of erectile dysfunction (ED), according to a new study by scientists at Albert Einstein College of Medicine of Yeshiva University.
More Nanoparticle Current Events and Nanoparticle News Articles
 |
Nanoparticles: From Theory to Application by Günter Schmid (Editor) An introduction to the science of nanoparticles, from fundamental principles to their use in novel applications. As a basis for understanding nanoparticle behavior, the book first outlines the principles of quantum size behavior, nanoparticles architecture, formation of semiconductor and metal nanoparticles. It then goes on to describe the chemical syntheses of nanoparticles with defined characteristics, their structural, electrical and magnetic properties, as well as current methods to monitor these properties. Among others, the following nanoparticle-based applications are discussed: * Single-electron devices * Ultra dense recording media * Bioelectronic devices and sensors * Labeling of proteins, nucleic acids and other biomaterials. ... |
 |
Nanoparticles Synthesis, Stabillization, passivation and Functionalization (Acs Symposium Series) by Ramanathan Nagarajan (Editor), T. Alan Hatton (Editor) Recent advances in the synthesis, stabilization, passivation and functionalization of a wide range of metal, metal oxide, semiconductor and other inorganic, polymer, organic, carbon and biological nanoparticles are reported in this book. Diverse shapes of nanoparticles are discussed here including spheres, cubes, nanorods, nanowires, nanotubes, nanocapsules, and nanopyramids. In the section on metals, one can find description of colloidal and wet chemical approaches to synthesize nanoparticles, methods to control number of functional groups and to attain aqueous dispersibility, impact of stabilizers on SERS activity, and ways to tune plasmon resonance via nanoparticle shapes. A time dependent density functional theory to evaluate adsorption properties of passivating ligands is also... |
 |
Nanoparticle Technology for Drug Delivery (Drugs and the Pharmaceutical Sciences) by Ram B. Gupta (Editor), Uday B. Kompella (Editor) Nanoparticles, products of nanotechnology, are of increasing interest to the pharmaceutical community. They can increase drug solubility, enhance bioavailability, allow tissue targeting, offer decreased side-effects, and improve therapeutic efficacy. Presenting the most pertinent and practical issues in the manufacturing and biological application of nanoparticles, this source presents state-of-the-art scientific contributions by seasoned authorities in the field. |
|
International Journal of Nanoparticles by Inderscience Enterprises Ltd | |
 |
Controlled Synthesis of Nanoparticles in Microheterogeneous Systems (Nanostructure Science and Technology) by Vincenzo Turco Liveri (Author) Because of their structural and dynamical properties, microheterogeneous systems have been employed as solvent and reaction media both to synthesize and stabilize nanoparticles. Following this route, inside their nanometer-sized heterogeneities the nanoparticles of many different substances have been incorporated. The book shows the distinct advantages of this synthetic strategy over that of many other methods. Moreover, it furnishes to the reader a collection of theoretical and experimental facts allowing him to reduce the number of trial and errors necessary to arrive at an optimal synthetic protocol. |
 |
Nanoparticles in Biomedical Imaging: Emerging Technologies and Applications (Fundamental Biomedical Technologies) by J.W. Bulte (Author), J.W. Bulte (Editor), Mike Modo (Editor) Fundamental Biomedical Technologies features titles in multidisciplinary, technology-driven areas, providing the foundations for breakthrough advances in medicine and biology. The term technology refers, in a vigorously unrestrictive sense, to a broad array of engineering disciplines, the sciences of computation and informatics, mathematical models exploiting and advancing methods of mathematical physics, and the development of novel, experimental discovery devices. Titles in this series are designed and selected to provide high-level visionary input for specialists, while presenting overviews of emerging fields for those in related areas. Volumes in this series aim to provide technologists with the material to gain competent entry into biomedical research and biomedical researchers to... |
 |
Creme De Jour Tinted by Marie Veronique Organics zinc oxide sunscreen no harmful chemicals no nanoparticles |
 |
Magnetic Nanoparticles by Sergey P. Gubin (Editor) This interdisciplinary approach to the topic brings together reviews of the physics, chemistry, fabrication and application of magnetic nanoparticles and nanostructures within a single cover. With its discussion of the basics as well as the most recent developments, and featuring many examples of practical applications, the result is both a clear and concise introduction to the topic for beginners and a guide to relevant comprehensive physical phenomena and essential technological applications for experienced researchers. |
 |
60 Minutes - The Kanzius Machine (April 13, 2008) Airdate: 04/13/08 John Kanzius has no medical degree. In fact, he doesn't even have a college degree. But Kanzius does have terminal cancer, and that has motivated him to invent a radio-wave machine with the idea of treating cancer without the debilitating side effects of chemotherapy and radiation. Lesley Stahl tells this remarkable story of a leukemia patient so moved by the suffering of children with cancer that he has devoted himself to finding a cure. This product is manufactured on demand using DVD-R recordable media. Amazon.com's standard return policy will apply. |
 |
Nanoparticle Technology Handbook by Masuo Hosokawa (Editor), Kiyoshi Nogi (Editor), Makio Naito (Editor), Toyokazu Yokoyama (Editor) Nanoparticle technology, which handles the preparation, processing, application and characterisation of nanoparticles, is a new and revolutionary technology. It becomes the core of nanotechnology as an extension of the conventional Fine Particle / Powder Technology. Nanoparticle technology plays an important role in the implementation of nanotechnology in many engineering and industrial fields including electronic devices, advanced ceramics, new batteries, engineered catalysts, functional paint and ink, Drug Delivery System, biotechnology, etc.; and makes use of the unique properties of the nanoparticles which are completely different from those of the bulk materials. This new handbook is the first to explain complete aspects of nanoparticles with many application examples showing... |
| © 2009 BrightSurf.com |